Bronchoscopy for Lung Cancer

Ohio State University Comprehensive Cancer Center, Columbus, OH
Lung CancerBronchoscopy - Procedure
Eligibility
18+
All Sexes

Study Summary

This trial is testing how well a needle aspiration guided by endobronchial ultrasound works in getting samples from patients suspected to have lung cancer that has spread to the nodules.

Eligible Conditions
  • Lung Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Up to 3 years

Up to 3 years
Number of samples collected via endobronchial ultrasound-guided transbronchial needle-aspiration with suction

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

Diagnostic (bronchoscopy with EBUS-TBNA with/without vacuum)
1 of 1

Experimental Treatment

263 Total Participants · 1 Treatment Group

Primary Treatment: Bronchoscopy · No Placebo Group · N/A

Diagnostic (bronchoscopy with EBUS-TBNA with/without vacuum)Experimental Group · 2 Interventions: Ultrasound-Guided Transbronchial Needle Aspiration, Bronchoscopy · Intervention Types: Procedure, Procedure
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bronchoscopy
2002
Completed Phase 2
~2250

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 3 years

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
295 Previous Clinical Trials
287,183 Total Patients Enrolled
Peter Kneuertz, MDPrincipal InvestigatorOhio State University Comprehensive Cancer Center

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

How many participants have been recruited to take part in this research?

"Indeed, the research posted on clinicaltrials.gov affirms that this trial is currently recruiting participants. It was first announced on August 31st 2020 and its latest update occurred June 13th 2022; 263 patients are required to be enrolled at a single site." - Anonymous Online Contributor

Unverified Answer

Is there still capacity available to enroll in this trial?

"According to clinicaltrials.gov, this research project is recruiting volunteers at present. The protocol was originally published on August 31st 2020 and experienced its most recent amendment on June 13th 2022" - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.